<DOC>
	<DOCNO>NCT01417377</DOCNO>
	<brief_summary>This observational , prospective , multi-centre , single-arm study evaluate efficacy Mircera ( methoxy polyethylene glycol-epoetin beta ) patient chronic kidney disease previously treatment short-acting epoetin alpha . Data collect 6 month .</brief_summary>
	<brief_title>An Observational Study Mircera ( Methoxy Polyethylene Glycol-epoetin Beta ) Anemic Patients With Chronic Kidney Disease ( NORM )</brief_title>
	<detailed_description />
	<criteria>Adult patient , age 18 year Chronic kidney disease ( CKD ) anemia Patients dialysis receive shortacting epoetin ( EPO ) Serum ferritin level &gt; /=100 ng/ml transferrin saturation ( TSAT ) &gt; /=20 % Patients unwilling give inform consent Uncontrolled hypertension Transfusion red blood cell within 8 week start Mircera treatment Relevant acute chronic bleed history Hemolysis Hemoglobinopathies Pure red cell aplasia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>